Niger vs Syrian Arab Republic: Previously treated cases tested for RR-/MDR-TB
Niger
33.0%
in 2024
Syrian Arab Republic
32.0%
in 2024
Niger rank
158th
Syrian Arab Republic rank
160th
Previously treated cases tested for RR-/MDR-TB over time
- Niger
- Syrian Arab Republic
How they compare
Niger currently reports 33.0% against 32.0% in Syrian Arab Republic, a difference of 1.0%.
The two have swapped places 7 times across 16 shared years of data; in 2009 it was Syrian Arab Republic ahead.
Niger ranks 158th and Syrian Arab Republic ranks 160th of 180 countries.
Syrian Arab Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Niger | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.8% | 8.0% | 3.2% | Syrian Arab Republic |
| 2010s | 44.2% | 50.3% | 6.1% | Syrian Arab Republic |
| 2020s | 76.6% | 86.4% | 9.8% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Niger or Syrian Arab Republic?
- Niger, at 33.0% against 32.0% in Syrian Arab Republic as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Niger and Syrian Arab Republic?
- 1.0%, with Niger ahead.
- How many years of comparable data are there for Niger and Syrian Arab Republic?
- 16 years are reported by both, from 2009 to 2024.
- How do Niger and Syrian Arab Republic rank globally for previously treated cases tested for rr-/mdr-tb?
- Niger ranks 158th and Syrian Arab Republic ranks 160th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.